Source: Eur Respir J, 57 (3) 2002226; 10.1183/13993003.02226-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yong Jun Choi, Ju-Young Park, Hye Sun Lee, Jin Suh, Jeung Yoon Song, Min Kwang Byun, Jae Hwa Cho, Hyung Jung Kim, Jae-Hyun Lee, Jung-Won Park, Hye Jung Park. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur Respir J, 57 (3) 2002226; 10.1183/13993003.02226-2020

Member's Comments

No comment yet.

Related content which might interest you: The impact of COVID-19 on patients with asthma Source: Eur Respir J, 57 (3) 2003142; 10.1183/13993003.03142-2020 Year: 2021 Impact of omalizumab in patients with severe asthma Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Ceruloplasmine efficacy in patients with asthma exacerbations Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Influence of personal characteristics of patients with bronchial asthma on their medication adherence Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Short-term effects of pulmonary rehabilitation on asthma control in patients with moderate-severe unstable asthma Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019 Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Combination asthma medication and healthcare use in severe or difficult-to-treat asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Influence of statin therapy on exacerbation frequency in patients with COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Impact of COVID-19 side-effects on pediatric and adult patients with recurrent wheeze and asthma Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Effects of lisinipril on hypertensive COPD and asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 718s Year: 2005 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Refining asthma treatment for mild asthma Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Effect of BMI on asthma control, asthma severity and quality of life in adult patients with asthma Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control Year: 2011 Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005 Efficacy of ruzam in the treatment of patients with mild-to-moderate asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015